2019
DOI: 10.1093/ehjcvp/pvz076
|View full text |Cite
|
Sign up to set email alerts
|

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF

Abstract: Aims Most clinical risk stratification models are based on measurement at a single time-point rather than serial measurements. Artificial intelligence (AI) is able to predict one-dimensional outcomes from multi-dimensional datasets. Using data from Global Anticoagulant Registry in the Field (GARFIELD)-AF registry, a new AI model was developed for predicting clinical outcomes in atrial fibrillation (AF) patients up to 1 year based on sequential measures of prothrombin time international normal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 44 publications
0
24
0
Order By: Relevance
“…There have been multiple applications of deep learning-based AI algorithms in the field of cardiology [20][21][22] . There are existing studies, using 12-lead ECG data to detect aortic stenosis [23] and mitral regurgitation [ [9]].…”
Section: Discussionmentioning
confidence: 99%
“…There have been multiple applications of deep learning-based AI algorithms in the field of cardiology [20][21][22] . There are existing studies, using 12-lead ECG data to detect aortic stenosis [23] and mitral regurgitation [ [9]].…”
Section: Discussionmentioning
confidence: 99%
“…It is of note that the guideline recommendation is only a guide. Recently developed computer-based artificial intelligence found more precise prediction of future clinical events from serially measured PT-INR [30], but a one-time measurement is still the standard.…”
Section: Discussionmentioning
confidence: 99%
“…Goto et al . 113 developed a model for predicting clinical outcomes, such as major bleeding, stroke/systemic embolism, and death, in newly diagnosed AF patients who were treated with vitamin K antagonists, using serial prothrombin time international normalized ratio values collected within 1 month after starting treatment. In a different article, Feeny et al .…”
Section: Risk Prediction Modelling With Ai/ml Methodsmentioning
confidence: 99%